When administering an alpha blocker for the first time, it is most important for the nurse to assess the patient for the development of what adverse effect?

Choice A rationale Alpha blockers primarily exert their effects on the vascular smooth muscle by blocking alpha-1 adrenergic receptors. This action leads to vasodilation, which lowers blood pressure. They do not have a direct mechanism of action that would precipitate acute renal failure upon first dose administration. Renal function, while monitored, is not the most immediate or common adverse effect to assess for. Choice B rationale Alpha-1 adrenergic receptors, when blocked by alpha blockers, cause vasodilation of both arteries and veins. This leads to a decrease in peripheral vascular resistance and venous return, causing a significant drop in blood pressure. This effect, known as orthostatic hypotension or "first-dose phenomenon," is a common and critical adverse effect to assess for, as it can cause dizziness and fainting. Choice C rationale Blood dyscrasias, or disorders involving the cellular components of blood, are not a typical or immediate adverse effect associated with the first administration of an alpha blocker. While some medications can cause these rare side effects over long-term use, the acute and most common concern with the initial dose is related to its cardiovascular effects on blood pressure. Choice D rationale While alpha blockers can indirectly affect the heart rate through baroreceptor reflexes in response to hypotension, they are not typically associated with the direct induction of significant dysrhythmias as a primary adverse effect upon first administration. The immediate and most profound hemodynamic effect is the peripheral vasodilation and subsequent hypotension, which takes precedence in initial assessment.